NLR-regulated pathways in cancer: opportunities and obstacles for therapeutic interventions.

Nidhi Sharma, Sushmita Jha

Journal: Cellular and molecular life sciences : CMLS 2016;73(9):1741-64

PMID: 26708292

Free Full Text on PubMed Central View on PubMed

Abstract

NLRs (nucleotide-binding domain, leucine-rich repeat containing receptors) are pattern recognition receptors associated with immunity and inflammation in response to endogenous and exogenous pathogen and damage associated molecular patterns (PAMPs and DAMPs respectively). Dysregulated NLR function is associated with several diseases including cancers, metabolic diseases, autoimmune disorders and autoinflammatory syndromes. In the last decade, distinct cell and organ specific roles for NLRs have been identified however; their roles in cancer initiation, development and progression remain controversial. This review summarizes the emerging role of NLRs in cancer and their possible future as targets for cancer therapeutics.

Address: Department of Biology, Indian Institute of Technology Jodhpur, Old Residency Road, Ratanada, Jodhpur, Rajasthan, 342011, India.; Department of Biology, Indian Institute of Technology Jodhpur, Old Residency Road, Ratanada, Jodhpur, Rajasthan, 342011, India. [email protected].

DOI: 10.1007/s00018-015-2123-8